Researchers and public health experts point to several overlapping factors, including poverty, lack of insurance coverage, ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

By Sneha S K May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six ...

Experts say prostate cancer remains a leading cause of cancer deaths in men. But new research at Yale shows that is likely to change. Dr. Nicholas Brutus, urology resident and lead author at the Yale ...

The Government’s plans for prostate cancer screening do not go far enough, experts have warned. James Murray, the new Health ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Those with prostate cancer that returns after surgery or radiation—and ...

Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 men screened, though the risk of overdiagnosis remains high, an updated Cochrane review ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Johnson & Johnson's Erleada drug, combined with hormone therapy, significantly reduces the risk of prostate cancer spread and ...